| Sailler, Laurent |
NCT05123586: A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus |
|
|
| Terminated | 2 | 85 | Europe, US, RoW | LY3361237, Placebo | Eli Lilly and Company | Systemic Lupus Erythematosus | 12/23 | 12/23 | | |
PREPCOV, NCT04481633: Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection |
|
|
| Recruiting | N/A | 800 | Europe | COVID 19 serology, COVID 19 Self-Questionnaire | University Hospital, Toulouse | COVID-19 | 03/22 | 03/22 | | |
LES-HYDROXY, NCT06161363: Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus |
|
|
| Recruiting | N/A | 50 | Europe | The Morisky Medication Adherence Scale | University Hospital, Toulouse | Lupus Erythematosus | 12/24 | 12/24 | | |
| MOULIS, Guillaume |
| Recruiting | 2 | 10 | Europe | Aspirin | University Hospital, Toulouse | Purpura, Thrombocytopenic | 01/25 | 09/25 | | |
PREPCOV, NCT04481633: Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection |
|
|
| Recruiting | N/A | 800 | Europe | COVID 19 serology, COVID 19 Self-Questionnaire | University Hospital, Toulouse | COVID-19 | 03/22 | 03/22 | | |
| Recruiting | N/A | 10000 | Europe | Medical information | University Hospital, Toulouse | Thrombocytopenia | 05/23 | 05/23 | | |
MATAC, NCT06444477: Molecular Analysis of Thrombocytopenia and Cancer (): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer |
|
|
| Not yet recruiting | N/A | 70 | Europe | ITP and cancer | University Hospital, Bordeaux | Immune Thrombocytopenia, Immune Thrombocytopenic Purpura, Neoplasms, Cancer | 12/24 | 12/24 | | |
